Results 271 to 280 of about 76,606 (312)
Some of the next articles are maybe not open access.
1998
Microalbuminuria, the abnormal urinary excretion of albumin, is recognised as an important independent marker of both renal and cardiovascular disease, particularly in diabetes mellitus. This volume is the only comprehensive and up-to-date review of the relevance of microalbuminuria to health and disease.
Peter H. Winocour, Sally M. Marshall
openaire +1 more source
Microalbuminuria, the abnormal urinary excretion of albumin, is recognised as an important independent marker of both renal and cardiovascular disease, particularly in diabetes mellitus. This volume is the only comprehensive and up-to-date review of the relevance of microalbuminuria to health and disease.
Peter H. Winocour, Sally M. Marshall
openaire +1 more source
Scandinavian Journal of Urology and Nephrology, 1992
Albumin excretion rate, glomerular filtration rate (GFR) and kidney volume in obese patients and normal-weight controls were compared with body mass index (weight (kg)/height2 (m)) in 17 subjects. Body mass index varied from 21.5 to 48.0, the albumin excretion rate from 2.8 to 17.8 micrograms/min, and the kidney volume from 238 to 468 ml.
N, Løkkegaard +2 more
openaire +2 more sources
Albumin excretion rate, glomerular filtration rate (GFR) and kidney volume in obese patients and normal-weight controls were compared with body mass index (weight (kg)/height2 (m)) in 17 subjects. Body mass index varied from 21.5 to 48.0, the albumin excretion rate from 2.8 to 17.8 micrograms/min, and the kidney volume from 238 to 468 ml.
N, Løkkegaard +2 more
openaire +2 more sources
Kidney International, 2014
Drug efficacy is ascertained using clinically meaningful outcomes that directly affect the well-being of patients. However, in studies of chronic kidney disease progression, clinically meaningful outcomes like end-stage renal disease take a long time to occur.
Roscioni, Sara S. +2 more
openaire +1 more source
Drug efficacy is ascertained using clinically meaningful outcomes that directly affect the well-being of patients. However, in studies of chronic kidney disease progression, clinically meaningful outcomes like end-stage renal disease take a long time to occur.
Roscioni, Sara S. +2 more
openaire +1 more source
Diabetes Care, 1993
OBJECTIVE To determine an effective screening procedure for microalbuminuria. RESEARCH DESIGN AND METHODS The prevalence of microalbuminuria in NIDDM patients whose urine was negative on routine Albustix testing was studied.
M M, Bashyam +4 more
openaire +2 more sources
OBJECTIVE To determine an effective screening procedure for microalbuminuria. RESEARCH DESIGN AND METHODS The prevalence of microalbuminuria in NIDDM patients whose urine was negative on routine Albustix testing was studied.
M M, Bashyam +4 more
openaire +2 more sources
Medical Journal of Australia, 1994
This statement summarises current understanding of the role of microalbuminuria in diabetic nephropathy and describes its natural history and clinical relevance. It outlines core facts and makes recommendations for the management of patients with persistent microalbuminuria.
G, Jerums +4 more
openaire +2 more sources
This statement summarises current understanding of the role of microalbuminuria in diabetic nephropathy and describes its natural history and clinical relevance. It outlines core facts and makes recommendations for the management of patients with persistent microalbuminuria.
G, Jerums +4 more
openaire +2 more sources
Impact of the severity of obesity on microalbuminuria in obese normotensive nondiabetic individuals
Journal of Renal Injury Prevention, 2015Introduction: Microalbuminuria has been now recognized as the most important risk factor for the increased morbidity and mortality in the obese population.
F. Minoo +3 more
semanticscholar +1 more source
Ugeskrift for laeger, 2009
Microalbuminuria is common in patients with hypertension and even lower levels of albuminuria reflect subclinical cardiovascular damage which is associated with increased cardiovascular risk. Reduction of albuminuria is associated with improved prognosis independently of reduction of blood pressure and regression of left ventricular hypertrophy ...
Michael Hecht, Olsen +2 more
openaire +1 more source
Microalbuminuria is common in patients with hypertension and even lower levels of albuminuria reflect subclinical cardiovascular damage which is associated with increased cardiovascular risk. Reduction of albuminuria is associated with improved prognosis independently of reduction of blood pressure and regression of left ventricular hypertrophy ...
Michael Hecht, Olsen +2 more
openaire +1 more source
cclm, 1998
Abstract Microalbuminuria is still the only early abnormality of the diabetic kidney that has an established prognostic value. Microalbuminuria evolves into clinical nephropathy and renal failure in a majority of cases of insulin-dependent diabetic patients, and is defined by the detection of urinary albumin excretion rates of 20–200 μg ...
openaire +2 more sources
Abstract Microalbuminuria is still the only early abnormality of the diabetic kidney that has an established prognostic value. Microalbuminuria evolves into clinical nephropathy and renal failure in a majority of cases of insulin-dependent diabetic patients, and is defined by the detection of urinary albumin excretion rates of 20–200 μg ...
openaire +2 more sources
Microalbuminuria: prognostic implications
Current Opinion in Nephrology and Hypertension, 1996Microalbuminuria is the presence of albumin above the normal but below the detectable range with the conventional urine dipstick methodology. Microalbuminuria is present in a variety of renal and non-renal diseases but only recently has its importance as a prognostic indicator been appreciated.
openaire +2 more sources